sisomicin has been researched along with dibekacin in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (66.67) | 18.7374 |
1990's | 1 (5.56) | 18.2507 |
2000's | 3 (16.67) | 29.6817 |
2010's | 2 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arakawa, Y; Ike, Y; Kimura, K; Kurokawa, H; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Kirikae, T; Kitao, T; Miyoshi-Akiyama, T | 1 |
Chow, JW; Frase, H; Smith, C; Toth, M; Vakulenko, SB | 1 |
Baltar, I; Esplugues, J; Marti, JL; Orts, A | 1 |
Yamamoto, M | 1 |
Schassan, HH; Witt, U | 1 |
Hara, T; Inouye, S; Kitasato, I; Matsuhashi, Y | 1 |
Billerey, C; Mallie, JP | 1 |
Price, KE | 1 |
Lüllmann, H; Schwarz, B | 1 |
Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ | 1 |
Azuma, K; Nishino, T; Saito, M; Tanino, T | 1 |
Noone, P | 1 |
Matsumoto, K; Noguchi, Y; Sakamoto, T; Taguchi, M; Takasugi, M | 1 |
Bopp, S; Marre, R; Sack, K; Schulz, E | 1 |
Deguchi, K; Furukawa, T; Hyodo, A; Miyake, Y; Uji, T | 1 |
Dahal, RK; Kirikae, T; Mishra, SK; Miyoshi-Akiyama, T; Ohara, H; Pokhrel, BM; Shimada, K; Tada, T | 1 |
2 review(s) available for sisomicin and dibekacin
Article | Year |
---|---|
The potential for discovery and development of improved aminoglycosides.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Lethal Dose 50; Mice; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1986 |
Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
Topics: Aging; Animals; Bacterial Infections; Dibekacin; Drug Interactions; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Humans; Kanamycin; Kidney Diseases; Netilmicin; Sisomicin | 1984 |
16 other study(ies) available for sisomicin and dibekacin
Article | Year |
---|---|
Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides.
Topics: Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Methyltransferases; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Plasmids; Protein Binding; Ribosome Subunits, Small; RNA, Ribosomal, 16S; Sequence Homology, Amino Acid | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
Topics: Acetylation; Acetyltransferases; Aminoglycosides; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2009 |
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
Topics: Aged; Amikacin; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Directed Molecular Evolution; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Gentamicins; Humans; Kinetics; Models, Molecular; Molecular Sequence Data; Mutagenesis; Mutation; Phosphotransferases (Alcohol Group Acceptor); Protein Structure, Tertiary; Recombinant Proteins; Sequence Homology, Amino Acid | 2010 |
[Neuromuscular inhibition of new aminoglycoside antibiotics].
Topics: Amikacin; Animals; Apnea; Dibekacin; Dose-Response Relationship, Drug; Gentamicins; Kanamycin; Mice; Neuromuscular Blocking Agents; Phrenic Nerve; Sisomicin; Streptomycin | 1979 |
[An experimental study on Pseudomonas osteomyelitis with special reference to the production of experimental osteomyelitis in mice (author's transl)].
Topics: Animals; Bacteriological Techniques; Dibekacin; Gentamicins; Mice; Osteomyelitis; Pseudomonas aeruginosa; Pseudomonas Infections; Sisomicin; Tibia | 1979 |
[Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
Topics: Amikacin; Bacteria; Dibekacin; Drug Resistance, Microbial; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Sisomicin; Tobramycin | 1979 |
Antimicrobial activity of dactimicin in vitro compared with that of dibekacin, netilmicin, sisomicin and micronomicin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dibekacin; Drug Resistance, Microbial; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Sisomicin | 1989 |
[Experimental study of nephrotoxicity: effects, on the newborn rat kidney, of aminoglycoside administration during gestation].
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Dibekacin; Female; Gentamicins; Kidney; Kidney Diseases; Maternal-Fetal Exchange; Microscopy, Electron; Pregnancy; Rats; Rats, Inbred Strains; Sisomicin | 1989 |
Effects of aminoglycoside antibiotics on bound calcium and contraction in guinea-pig atria.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Calcium; Depression, Chemical; Dibekacin; Gentamicins; Guinea Pigs; Heart Atria; In Vitro Techniques; Myocardial Contraction; Myocardium; Sisomicin | 1985 |
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1980 |
[Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Cefotaxime; Cefotetan; Cefsulodin; Cephalosporins; Cephamycins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Escherichia coli; Kanamycin; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Sisomicin | 1983 |
[Aerosol administration of dibekacin--the sputum concentration].
Topics: Adult; Aerosols; Aged; Animals; Bronchitis; Dibekacin; Drug Evaluation; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Rabbits; Respiratory Therapy; Sisomicin; Sputum | 1983 |
[Animal experiments on the nephrotoxicity, pharmacokinetics and therapeutic efficacy of dibekacin].
Topics: Animals; Dibekacin; Enzyme Activation; Female; Kanamycin; Kidney Diseases; Kinetics; Malate Dehydrogenase; Rats; Sisomicin | 1981 |
[Therapeutic efficacy of cefodizime in combination with aminoglycosides against systemic infections caused by Pseudomonas aeruginosa in immunocompromised tumour bearing mice].
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Immunocompromised Host; Male; Mice; Mice, Inbred Strains; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Sisomicin | 1993 |
Identification of a novel 6'-N-aminoglycoside acetyltransferase, AAC(6')-Iak, from a multidrug-resistant clinical isolate of Stenotrophomonas maltophilia.
Topics: Acetyltransferases; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Neomycin; Netilmicin; Sisomicin; Stenotrophomonas maltophilia; Tobramycin | 2014 |